We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$9.36B
AUM Growth
+$632M
Cap. Flow
-$6.88M
Cap. Flow %
-0.07%
Top 10 Hldgs %
45.21%
Holding
680
New
80
Increased
120
Reduced
160
Closed
49

Top Buys

Rank Stock Value
1
PH icon
Parker-Hannifin
PH
+$16.7M
2
WEX icon
WEX
WEX
+$15.9M
3
EOG icon
EOG Resources
EOG
+$8.51M
4
ASML icon
ASML
ASML
+$7.23M
5
PAYC icon
Paycom
PAYC
+$6.13M

Top Sells

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$14.1M
2
SYK icon
Stryker
SYK
+$9.82M
3
CRM icon
Salesforce
CRM
+$8.96M
4
DIS icon
Walt Disney
DIS
+$8.1M
5
MSFT icon
Microsoft
MSFT
+$7.62M

Sector Composition

Rank Sector Weight
1 Technology 37.6%
2 Healthcare 18.75%
3 Financials 10.69%
4 Consumer Discretionary 10.29%
5 Communication Services 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIDU icon
476
Baidu
BIDU
$35.2B
$27.4K ﹤0.01%
200
SONY icon
477
Sony
SONY
$137B
$27K ﹤0.01%
1,500
WMS icon
478
Advanced Drainage Systems
WMS
$11.1B
$26.5K ﹤0.01%
233
+113
+94% +$10.7K
IBMM
479
DELISTED
iShares iBonds Dec 2024 Term Muni Bond ETF
IBMM
$26.3K ﹤0.01%
+1,020
New +$26.2K
DUK icon
480
Duke Energy
DUK
$96.7B
$25.4K ﹤0.01%
283
MTR
481
Mesa Royalty Trust
MTR
$5.33M
$25.3K ﹤0.01%
+1,029
New +$22.2K
KR icon
482
Kroger
KR
$34.8B
$25.2K ﹤0.01%
537
WASH icon
483
Washington Trust Bancorp
WASH
$765M
$24.6K ﹤0.01%
919
CRSP icon
484
CRISPR Therapeutics
CRSP
$5.2B
$24.4K ﹤0.01%
435
-200
-31% -$11.3K
BKH icon
485
Black Hills Corp
BKH
$5.64B
$24.1K ﹤0.01%
+400
New +$25.4K
GHRS icon
486
GH Research
GHRS
$1.97B
$23.7K ﹤0.01%
+2,000
New +$20.5K
VTR icon
487
Ventas
VTR
$46.4B
$23.6K ﹤0.01%
500
TTWO icon
488
Take-Two Interactive
TTWO
$45.1B
$23.5K ﹤0.01%
160
NTAP icon
489
NetApp
NTAP
$40.3B
$22.9K ﹤0.01%
300
PLUG icon
490
Plug Power
PLUG
$3.16B
$22.9K ﹤0.01%
2,200
+105
+5% +$956
AZN icon
491
AstraZeneca
AZN
$245B
$22.8K ﹤0.01%
159
FMS icon
492
Fresenius Medical Care
FMS
$12.6B
$22.2K ﹤0.01%
926
QCLN icon
493
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$634M
$22.1K ﹤0.01%
432
IXUS icon
494
iShares Core MSCI Total International Stock ETF
IXUS
$60.8B
$22K ﹤0.01%
+352
New +$22K
VSTM icon
495
Verastem
VSTM
$615M
$21.9K ﹤0.01%
2,949
LBRDA icon
496
Liberty Broadband Class A
LBRDA
$5.15B
$20.4K ﹤0.01%
256
UNB icon
497
Union Bankshares
UNB
$120M
$20.3K ﹤0.01%
875
-225
-20% -$4.93K
CDZI icon
498
Cadiz
CDZI
$301M
$20.3K ﹤0.01%
5,000
ICE icon
499
Intercontinental Exchange
ICE
$85.3B
$20K ﹤0.01%
177
CSL icon
500
Carlisle Companies
CSL
$14.9B
$19.8K ﹤0.01%
77

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Loring Wolcott & Coolidge Fiduciary Advisors held 680 positions worth $9.36B, up 7.2% from $8.73B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2023 filing shows 80 new, 120 increased, 160 reduced and 49 closed positions. Its largest new stake was Select Medical: 182,558 shares worth $3.13M. The largest sale was IQVIA, an estimated $14.1M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q2 2023 buy was Select Medical: 182,558 shares worth $3.13M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Parker-Hannifin in Q2 2023, an estimated $16.7M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q2 2023 reduction was IQVIA, cutting an estimated $14.1M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2023, selling an estimated $890K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 45% of its $9.36B portfolio in Q2 2023.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 80 new positions and closed 49 in Q2 2023.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 7.2% quarter-over-quarter to $9.36B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.